Andreia Albuquerque
8 Papers
6 Citations
Andreia Albuquerque is an academic researcher. The author has contributed to research in topics: Myeloid leukemia & Medicine. The author has an hindex of 2, co-authored 5 publications.
Chat about Author
Papers
Karyotype evolution and acquisition of FLT3 or RAS pathway alterations drive progression of myelodysplastic syndrome to acute myeloid leukemia
Manja Meggendorfer,Andreia Albuquerque,Nirsoshan Nadarajah,Tamara Alpermann,Wolfgang Kern,Kimberly Steuer,Karolína Perglerová,Claudia Haferlach,Susanne Schnittger,Torsten Haferlach +9 more
TL;DR: Myelodysplastic syndromes are a heterogeneous group of myeloid neoplasms associated with aberrant myeloids differentiation and ineffective hematopoiesis leading to cytopenias and in more than 20% of affected patients the MDS transforms into secondary acuteMyeloid leukemia (s-AML).
32
Impact of human papillomavirus vaccine against anal human papillomavirus infection, anal intraepithelial neoplasia, and recurrence of anal intraepithelial neoplasia: a systematic review and meta-analysis.
TL;DR: In this article , the authors performed a literature review and meta-analysis to estimate vaccine efficacy/effectiveness against anal HPV infection and anal intraepithelial neoplasia (AIN).
9
Diagnostic and Prognostic Utility Of a 26-Gene Panel For Deep-Sequencing Mutation Analysis In Myeloid Malignancies
Alexander Kohlmann,Sabrina Kuznia,Niroshan Nadarajah,Tamara Alpermann,Sandra Weissmann,Andreas Roller,Andreia Albuquerque,Wolfgang Kern,Claudia Haferlach,Susanne Schnittger,Torsten Haferlach +10 more
TL;DR: The utility of the pan-myeloid panel in MDS was addressed when the analysis was restricted to the five prognostically relevant predictors of poor overall survival according to Bejar et al.
2
Possible Biomarkers To Predict Response In Patients With Myelodysplastic Syndromes (MDS) Or Acute Myeloid Leukemia (AML) Treated With 5-Azacitidine
Andrea Kuendgen,Catharina Müller-Thomas,Petra Urbaniak,Michael Lauseker,Torsten Haferlach,Tamara Alpermann,Andreia Albuquerque,Alexander Kohlmann,Susanne Schnittger,Barbara Hildebrandt,Brigitte Royer-Pokora,Norbert Gattermann,Rainer Haas,Ulrich Germing,Katharina Götze +14 more
TL;DR: This study analyzes 71 patients with MDS or AML, treated with at least 3 cycles of aza, to identify prognostic indicators that might help to improve treatment decisions and assess the impact of biomarkers.
2
A 13-Gene Panel Targeted To Investigate CLL By Next-Generation Amplicon Deep-Sequencing Can Be Successfully Implemented In Routine Diagnostics
Alexander Kohlmann,Andreas Roller,Andreia Albuquerque,Sabrina Kuznia,Sandra Weissmann,Sabine Jeromin,Wolfgang Kern,Claudia Haferlach,Susanne Schnittger,Torsten Haferlach +9 more
TL;DR: A sensitive deep-sequencing assay that robustly target 13 genes for next-generation sequencing in a routine diagnostics environment and provides the potential to screen for prognostically relevant mutations in chronic lymphocytic leukemia patients.
1